News

The Royal Marsden Pioneers Online Adaptive Radiotherapy Treatment

The Royal Marsden Pioneers Online Adaptive Radiotherapy Treatment

The Royal Marsden NHS Foundation Trust's Landmark Achievement

In a world-first milestone, The Royal Marsden NHS Foundation Trust has successfully treated a patient using a state-of-the-art adaptive replanning module integrated within RayStation software for online adaptive radiotherapy. RaySearch Laboratories AB (publ) has been instrumental in making this revolutionary technology available. The patient, who underwent treatment for endometrial cancer, was treated using the advanced Radixact linear accelerator, showcasing the synergy of cutting-edge technology and care in oncology.

Innovations in Cancer Treatment Technology

This achievement exemplifies the significant advancements in cancer treatment technologies, particularly the adaptability of therapies to patients' current anatomical conditions. The Royal Marsden is at the forefront of integrating such innovative solutions, aiming to enhance treatment precision and efficiency. The collaboration between The Royal Marsden and RaySearch focuses not only on utilizing existing technologies but also on pushing the boundaries towards the continuous improvement of patient care processes.

The Role of Technology in Personalized Care

Dr. Susan Lalondrelle, a Consultant Clinical Oncologist at The Royal Marsden, expressed immense pride in this pioneering venture. She stated, "We are extremely proud to be the first cancer center in the world to treat a patient using RaySearch's advanced online adaptive radiotherapy technology. The ability to personalize treatment sessions based on the patient's real-time anatomy represents a transformative progression in cancer care." This approach aims to make each patient's experience more tailored and relevant to their unique needs during treatment.

Future Directions for Radiation Therapy

The ongoing partnership between The Royal Marsden and RaySearch will involve further developments in the integration of RaySearch's oncology information system, RayCare. This enhancement is anticipated to contribute to quicker treatment times and better patient outcomes. The shared goal is not merely to adapt existing processes but to innovate and evolve how radiation therapy is administered across diverse clinical setups.

About The Royal Marsden and Its Vision

Established in 1851 as the first hospital dedicated exclusively to cancer care, The Royal Marsden has earned an unparalleled reputation for excellence in cancer treatment, research, and education. Together with its partner, The Institute of Cancer Research (ICR), it has become Europe's largest cancer center, providing care for more than 59,000 patients yearly. As a leader in cancer innovation, The Royal Marsden continues to pave the way for new treatments and methodologies to improve patient outcomes.

RaySearch's Commitment to Advanced Oncology Solutions

RaySearch Laboratories AB (publ) is recognized for developing innovative software that improves cancer treatment processes. Their products, including the RayStation treatment planning system and the RayCare oncology information system, have gained traction across over 1,100 clinics worldwide. With a history stemming from the esteemed Karolinska Institute, RaySearch remains dedicated to enhancing the efficacy and efficiency of cancer care through advanced technological solutions.

Frequently Asked Questions

What is the significance of this treatment at The Royal Marsden?

This treatment marks the first instance of using the adaptive replanning module within RayStation for online adaptive radiotherapy, setting a precedent in cancer care.

How does online adaptive radiotherapy benefit patients?

Online adaptive radiotherapy personalizes treatment by adjusting to changes in the patient's anatomy in real time, thereby enhancing treatment accuracy and efficacy.

What technologies were involved in the treatment?

The treatment utilized RayStation software in conjunction with Accuray's Radixact linear accelerator, showcasing integrated healthcare solutions.

What future developments are expected?

Further enhancements are anticipated through the integration of RayCare, which aims to streamline treatment processes and improve patient experience.

What is The Royal Marsden's mission?

The Royal Marsden's mission is to lead in cancer treatment technology and research, providing the highest quality of care to patients while pioneering groundbreaking innovations.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

First FedRAMP® 20x Class C Certification Earned

Updated Category News Views 0

Shifting Landscapes in Cybersecurity Certifications Change is the only constant in tech, and 360 Advanced sure knows how to ride that wave by leaping into the murky waters of FedRAMP's newest class. They’ve stamped their name on this historic FedRAMP® 20x Class C Certification by playing the role of the independent assessor for Perplexity's cloud service—a first...

Continue Reading
PSEG Q3 2026: Mixed Earnings Amidst Storms and Stability

Updated Category News Views 93

Decoding PSEG's Q3 2026 Performance A company's quarterly performance can feel a bit like checking the weather: you are never quite sure what's coming your way. For PSEG's (NYSE: PEG) third quarter of 2026, the skies were full of mixed signals. Just looking at the headline earnings number, $0.76 per share in net income, there's a drop from last year's $1.24. That’s a...

Continue Reading
PRA Group Marks 30 Years with Nasdaq Bell Ringing

Updated Category News Views 61

A Milestone in Times Square Thirty trips around the sun, and here we are: PRA Group, the change-maker in the world of nonperforming loans, is celebrating by ringing the Nasdaq Opening Bell. It's a pretty big to-do in the financial world to get this nod, standing out in New York City's Times Square, no less. This shindig showcased Martin Sjolund, their President and CEO,...

Continue Reading
Martin's Holiday Heatwave: Mixing Summer Flavors

Updated Category News Views 27

Holiday Heatwave Meets Winter Cheer with Martin's Rolls Hold onto your oven mitts, folks, because Martin’s Famous Potato Rolls and Bread is stirring up the winter doldrums with an unexpected twist this holiday season. Forget the old cranberry sauce routine—it’s all about mixing sunny vibes with frosty festivities in their "Very Merry Martin’s: Holiday Heatwave."...

Continue Reading
Silicone Fluids Market Forecast Hits $10.15B by 2031

Updated Category News Views 113

Unpacking the Prevailing Expansion The global silicone fluids market is marching on a path to significant growth, projected to hit a hefty $10.15 billion by 2031. Now, if you think that's just another number, let's break down why this matters and how the market is changing its stripes. The Rising Tide of Silicone Applications Silicone fluids are not just sliding under the...

Continue Reading
Neros & the $615M Push: America’s Drone Ambitions

Updated Category News Views 45

Unveiling America's Drone Manufacturing Surge Straight talk, folks—there's a roaring play on the horizon with drones, and Neros is right at the spearhead. A fresh $450 million conditional loan from the Office of Strategic Capital (OSC) is lighting up the field, and if you're not paying attention, you're already falling behind. Add $165 million more in cold hard Neros...

Continue Reading
Ebix and intentyx Tackle AI Security in Regulated Fields

Updated Category News Views 115

Ebix Aims to Rein in AI Mischief When you throw AI agents into the mix of regulated businesses like insurers, banks, and healthcare outfits, you get a storm brewing. Now, Ebix and intentyx seem to be donning their capes, aiming to bring clarity with their new SMARE security platform. Fancy name notwithstanding, this isn't about mind games—it's about real, observable...

Continue Reading
New Paths Emerge in Thin Film Dewetting Control

Updated Category News Views 46

The Thin Film Challenge: Decoding Dewetting Ah, dewetting—it's a bit like trying to keep a chocolate bar solid on a scorching summer day. These thin films, they're supposed to hold their own, spread thin and steady. But apply a little heat or a laser, and watch them form tiny islands, like a retreating tide. Now, there's some fresh thinking in the air, straight from...

Continue Reading
Aosom Unveils Its Boldest Black Friday Extravaganza

Updated Category News Views 67

Black Friday Heat Kicks Off Early at Aosom All the seasoned shoppers out there smell a deal from a mile away, and Aosom isn't taking any chances by launching their Black Friday bash smack dab on November 2nd. This isn’t just any sale, it’s shaping up to be their most gigantic festival of discounts yet. Across Europe and North America, folks are rubbing their hands...

Continue Reading
Lakeland Builds Apartments; Screening Rules Cause Snags

Updated Category News Views 111

What's the Real Trouble in Lakeland? The Lakeland metro area surely ain't short on apartments after a colossal building frenzy. We're talking a solid 40% bump in just the past five years. You'd figure that'd be enough to solve any housing squeeze, right? But here's the kicker: vacancy rates are stuck at 11.8% — way over the national mean of 7.9%. Discounts like two...

Continue Reading

Top 5 Most Recently Viewed Articles

Elanco Animal Health Q4 Report: Good News? Buyer Beware

Updated Category News Views 197

Elanco's Mixed Bag of Earnings Let’s cut to the chase: Elanco Animal Health, trading on NYSE as ELAN, just wrapped up their Q4 earnings call and it’s, well, a bit of a head-scratcher. They beat estimates, which sounds great on paper, reporting an EPS of $0.13—18.18% above the forecasted $0.11. So, why does this kinda tick me off? Because we’ve got some underlying...

Continue Reading
AutoNation Schedules Earnings Call for Q3 Results

Updated Category News Views 156

AutoNation's Upcoming Earnings Conference Call AutoNation, Inc. (NYSE: AN) has announced its plans to release the financial results for the third quarter, concluding on September 30. This significant announcement is scheduled for Thursday, when the financial results will be available prior to market opening. AutoNation's management team is enthusiastic about sharing the...

Continue Reading
Dionysos AS Enhances Stake in Hexagon Purus with New Purchase

Updated Category News Views 247

Dionysos AS Enhances Stake in Hexagon Purus with New Purchase (Oslo, Norway) In a recent financial move, Dionysos AS has acquired 82,500 shares of Hexagon Purus ASA, with the transaction reflecting an average price of NOK 5.9739 per share. This increase in ownership demonstrates the growing confidence in Hexagon Purus' innovative solutions for zero-emission mobility....

Continue Reading
Dierks Bentley Launches ROW 94 Whiskey with Unique Craftsmanship

Updated Category News Views 215

Dierks Bentley Launches ROW 94 Whiskey Country music icon Dierks Bentley is thrilled to introduce his very first whiskey, ROW 94. This distinctive bourbon is crafted at the historic Green River Distilling Co. and is made using just Three Ingredients and The Truth. Bentley aimed to create a whiskey that resonates with his own experiences and those of his fans, making it...

Continue Reading
How $100 in Citigroup Transformed into $219.17 Over 5 Years

Updated Category News Views 183

Understanding Citigroup's Investment Journey Citigroup (C) has demonstrated an impressive performance over the last five years. By outpacing the market by 2.48% annually, the company has produced an average annual return of 17.34%. This compelling performance has contributed to Citigroup's market capitalization, which currently stands at $183.72 billion. The Impact of a...

Continue Reading